Founder and CEO at BioTrillion, a health technology company developing “digital biomarkers” to enable ordinary consumers with extraordinary health insights.
Previously spent over decade as a Healthcare Investment Banker at Citigroup, Deutsche Bank. From Analyst through Managing Director, executed M&A, IPO deals across the spectrum of drug, diagnostic, and device technologies.
Began career as a Bioengineer at Life Technologies.
M.S.E. in Bioengineering @ UPenn.
B.S.E. in Bioengineering @ Berkeley.
Invited by: Jeff Herbst
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
November 01, 2023 | 96 | +2 | +2.2% |
October 30, 2022 | 94 | +1 | +1.1% |
June 12, 2022 | 93 | -1 | -1.1% |
November 15, 2021 | 94 | +1 | +1.1% |
October 08, 2021 | 93 | +1 | +1.1% |
August 26, 2021 | 92 | +5 | +5.8% |